Photo via Toronto Star

Altrova Health to Present at the Life Sciences Investor Forum on September 17th

Read the original at Toronto Star ↗
Cite

Altrova Health to Present at the Life Sciences Investor Forum on September 17th. (2026, September 15). Toronto Star. https://www.thestar.com/globenewswire/altrova-health-to-present-at-the-life-sciences-investor-forum-on-september-17th/article_023df25d-077a-5eee-ae7e-f1ea051332ad.html

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Toronto Star · collected 2026-09-15 · by GlobeNewswire, Inc.

Quick Summary

Geoff Benic, CEO of Altrova Health Inc., will present at the Life Sciences Investor Forum on September 17th at 2:30 PM ET. The forum, hosted by VirtualInvestorConferences.com, allows real-time interaction with investors and industry professionals. Recently, Altrova signed a two-year exclusive distribution agreement in the U.S. with Reliability Funding LLC for certain products, along with raising up to US$500,000 through a private placement to support the launch. The company also reported its first commercial revenue of $112,000 for nine months ending June 30, 2026, an increase from $15,551 in the previous period.
Written by AI on 2026-09-16, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Avicanna Inc., a Canadian biopharmaceutical company focused on cannabinoid-based medicines, announced that its CEO Aras Azadian will present at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026, starting at 10:30 am Eastern Time. The forum provides a platform for investors and industry professionals to engage with company management through live Q&A sessions. Additionally, Altrova Health Inc., another Canadian company focused on health and safety technologies, announced that its CEO Geoff Benic will present at the same event later that day at 2:30 pm Eastern Time. Both companies recommend pre-registration for a smoother participation experience. On September 18th, Virtual Investor Conferences released that all presentations from the Life Sciences Virtual Investor Forum were available for on-demand viewing.

Written for “Life Sciences Investor Forum Presenta…” on 2026-11-03, grounded in this article and the 2 other(s) covering the same event.

Story

📰 Life Sciences Investor Forum Presenta…
Health · 3 article(s) covering the same event. See how they differ ↓

Compared with similar articles

This article reads unscored and hedges 0% of its claims. Each row says how that neighbour differs.
Toronto Star
Hedges 0 of 2 claims Outlet record 64/100
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
17
sentences that state something as happening or true
Uncertain
0%
0 of 17 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
64/100
Toronto Star's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
3
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-16 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Toronto Star · 11229 article(s) · 28 correction(s) detected
Running correction rate · 28 correction(s)
2026-10-26
Correction
2026-10-24
Correction
2026-10-07
Correction
2026-09-24
Correction

Who wrote this

No reporter is named on this article, beyond the feed's “GlobeNewswire, Inc.”.

Topics

Altrova Health Inc. NIRLAB ROVA Reliability U.S.

Subjects

Altrova Health Inc. ORG · 4× Reliability ORG · 3× U.S. GPE · 3× ATVHF ORG · 2× Altrova Health ORG · 2× Geoff Benic PERSON · 2× NIRLAB ORG · 2× NIRLAB SA ORG · 2× ROVA ORG · 2× WF8 ORG · 2×

Narrative

Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) (“Altrova Health” or the “Company”), based in Canada, focused on health, safety, and rapid response technologies, today announced that Geoff Benic, Chief Executive Officer, will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026 DATE: September 17th TIME: 2:30 PM ET The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time.
framing: assertive · carried by 1 article(s) · first seen 2026-09-16
🔮 Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) (“Altrova Health” or the “Company”), based in Canada, focused on health, safety, and rapid response technologies, today announced that Geoff Benic, Chief Executive Officer, will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026 DATE: September 17th TIME: 2:30 PM ET The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time.

Claims (17 extracted, 0 hedged)

Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) (“Altrova Health” or the “Company”), based in Canada, focused on health, safety, and rapid response technologies, today announced that Geoff Benic, Chief Executive Officer, will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026 DATE: September 17th TIME: 2:30 PM ET The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time. asserted
event → base → time
A replay of the webcast will be available following the conclusion of the conference. asserted
replay → follow → conference
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. asserted
investors → recommend → updates
Recent Company Highlights - Exclusive U.S. Distribution Agreement – The Company entered into an exclusive distribution agreement with Reliability Funding LLC (“Reliability”), appointing Reliability as its exclusive sales agent and distributor for the Company’s detection, protection and wellness product portfolio across the United States (excluding the NIRLAB SA (“NIRLAB”) NIRLIGHT device). asserted
Company → enter → device
The agreement has an initial two-year term with renewal tied to agreed performance thresholds, and Reliability is compensated through a share of profit on U.S. sales. asserted
Reliability → have → sales
Concurrently, the Company announced a non-brokered private placement for gross proceeds of up to US$500,000 to fund inventory, customer onboarding and sales support for the U.S. launch. asserted
Company → announce → launch
- First Commercial Revenue in Company History – For the nine months ended June 30, 2026, the Company reported revenue of $112,000, up from $15,551 in the prior comparative period, asserted
Company → end → period
as distribution and commercialization initiatives began converting into recurring commercial activity. asserted
initiatives → begin → activity
General and administrative, investor relations and professional fees each declined year-over-year even as commercial operations scaled. asserted
operations → decline → year
- Board Leadership Transition – The Board appointed The Hon. Tony Clement as Chairman of the Board of Directors of Altrova Health. asserted
Board → appoint → Health
The Company also continued to expand its distribution network through NIRLAB device sales, partnerships with Indigenous and First Nations communities, and a planned relaunch of the Drug Lab 118 Ltd. rapid detection strip portfolio. asserted
Company → continue → portfolio
Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment, and wellness. asserted
Inc. → build → detection
The Company’s current product portfolio includes exclusive Canadian distribution rights for the NIRLAB SA (“NIRLAB”) NIRLIGHT drug analysis device, the O-Spray product line, and the rapid detection strip portfolio of its subsidiary Drug Lab 118 Ltd. asserted
portfolio → include → Ltd.
About Virtual Investor Conferences® Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. asserted
companies → lead → investors
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. asserted
VIC → provide → access
Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. asserted
VIC → replicate → content
Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. asserted
Conferences → accelerate → investors
💬Give feedback
🕘History 🎫Support